Circular Genomics has created the first ever circular RNA-based test to predict a patient’s response to selective serotonin-reuptake inhibitor antidepressant treatment.
Circular Genomics’ goal is to make fundamental improvements to the standard of care in depression and support physicians in choosing the most effective treatments more rapidly.
コメント